1. Styers D, Sheehan DJ, Hogan P, Sahm DF: Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob. 2006, 5: 2-10.1186/1476-0711-5-2.
2. Johnson AP: Methicillin-resistant Staphylococcus aureus: the European landscape. J Antimicrob Chemother. 66 (Suppl 4): iv43-iv48.
3. European Centre for Disease Prevention and Control: Antimicrobial resistance surveillance in Europe 2010. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 2011, Stockholm: ECDC
4. Melo-Cristino JAAF, Amorim JM, Diogo J, Lito LM, Lopes P, Marques J, Marques T, Martins F, Monteiro L, Nascimento I, Pessanha MA, Piedade J, Ramos MH, Ribeiro G, Rodrigues A, Salgado MJ, Sobral L, Spencer D: Estudo multicê ntrico de resistê ncia aos antimicrobianos em nove hospitais portugueses. Comparaç ã o de resultados num intervalo de uma dé cada. Revista Portuguesa de Doenç as Infecciosas. 2006, 3: 7-15.
5. Jones RN: Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains. Clin Infect Dis. 2006, 42 (Suppl 1): S13-S24.